Zika Virus Vaccines


The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.


    Related Conference of Zika Virus Vaccines

    September 08-09, 2025

    45th Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    September 08-09, 2025

    6th International Conference on Vaccine Research

    Paris, France
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands
    October 06-07, 2025

    37th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada

    Zika Virus Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in